MARKET

BTAI

BTAI

BIOXCEL THERAPEU
NASDAQ

Real-time Quotes | Nasdaq Last Sale

16.67
-0.78
-4.47%
After Hours: 16.67 0 0.00% 16:30 01/17 EST
OPEN
17.50
PREV CLOSE
17.45
HIGH
17.80
LOW
16.38
VOLUME
202.24K
TURNOVER
--
52 WEEK HIGH
19.89
52 WEEK LOW
3.760
MARKET CAP
300.64M
P/E (TTM)
-8.2260
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BTAI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BTAI News

  • PTLA, NKTR, SRNE and SIX among midday movers
  • Seeking Alpha - Article.01/10 17:43
  • BTAI: Potentially Transformative Year Ahead for BioXcel
  • Zacks Small Cap Research.01/10 11:45
  • H.C. Wainwright Maintains Buy on BioXcel Therapeutics, Raises Price Target to $30
  • Benzinga.01/08 15:44
  • BioXcel Therapeutics Announces First Patient Enrolled In Phase 1b/2 Study Of BXCL501 For Acute Treatment Of Agitation Associated With Dementia
  • Benzinga.01/07 12:15

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About BTAI

BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company that is focused on the development of drugs for psychiatric disorders and rare cancers. The Company uses novel artificial intelligence (AI) for drug re-innovation processes of approved product candidates to identify new therapeutic indices. Its principal clinical development programs are BXCL501 and BXCL701. BXCL501 is a sublingual thin film formulation of dexmedetomidine (Dex) designed for the acute treatment of agitation resulting from neurological and psychiatric disorders. BXCL701 is an immuno-oncology agent designed for the treatment of prostate and pancreatic cancer.
More

Webull offers BioXcel Therapeutics Inc (BTAI) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.